Knowledge hub

Blog

AI at the Forefront of Modern Radiology Analysis: Brain MRI Use Case

webinar HCS
Game-Changing Insights in HCS with Cell Painting
AI-driven method for identification of hits from phenotypic screening with Cell Painting Assay
Hackathon – March 2023
Ardigen and DKFZ Research Groups Collaborate to Evaluate the TCR-based Therapies (TCR-Ts)
Ardigen at SLAS International Conference & Exhibition 2023
Meet Ardigen phenAID platform
Ardigen at PMWC 2023
News

Mariola Fotin-Mleczek, PhD, Has Joined Ardigen’s Scientific Board

Ardigen supports JUMP-CP Consortium – The World’s Largest Public Cell Painting Dataset
Agnieszka Blum, MD, PhD, Promoted to the Ardigen Management Board
Prof. Dr. med. Michael Schmitt, MHBA in Ardigen’s Scientific Board
Łukasz Dutkiewicz, PhD Welcomed in Ardigen as a Business Development Director
Discover Our Gene Regulation Platform
Unconventional γδ T cells as allogeneic cellular products in immunotherapies for cancer.
Boost Your Way to Successful Therapy: AI for Drug Discovery Days
Ardigen – New Corporate Identity